Design and evaluation of prostaglandin E1 (PGE1) intraurethral liquid formulation employing self-microemulsifying drug delivery system (SMEDDS) for erectile dysfunction treatment

Biological and Pharmaceutical Bulletin

Volumn 31, Issue 4, 2008, Pages 668-672

  Lee, Sangkil ^a   Lee, Jaehwi ^b   Choi, Young Wook ^b  

^a Inje University   (South Korea)

^b Chung Ang University   (South Korea)

Author keywords

Erectile dysfunction; Intraurethral; Prostaglandin E1; Self emulsifying drug delivery system

Indexed keywords

ALCOHOL; CREMOPHOR; CREMOPHOR ELP; LABRAFAC CC; OIL; PROSTAGLANDIN E1; UNCLASSIFIED DRUG; WATER;

ANIMAL EXPERIMENT; ARTICLE; CAT; CONTROLLED STUDY; DRAIZE TEST; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG EFFICACY; DRUG FORMULATION; DRUG SAFETY; DRUG STABILITY; ERECTILE DYSFUNCTION; FLUID FLOW; GEL; LABORATORY TEST; LIQUID INTRAURETHRAL DRUG DELIVERY SYSTEM; MALE; MASS; MICROEMULSION; MICTURITION; MOISTURE; NONHUMAN; PENIS; PRESSURE; REFLEX; SELF MICROEMULSIFYING DRUG DELIVERY SYSTEM; VISCOSITY;

ALPROSTADIL; ANIMALS; CATS; CHEMISTRY, PHARMACEUTICAL; DRUG DELIVERY SYSTEMS; EMULSIONS; ERECTILE DYSFUNCTION; EXCIPIENTS; INJECTIONS; IRRITANTS; MALE; PARTICLE SIZE; PENILE ERECTION; PENIS; RABBITS; SOLVENTS; URETHRA; VASODILATOR AGENTS; VISCOSITY;

EID: 41849143050     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.31.668     Document Type: Article

References (28)

1. Virag R., Shoukry K., Floresco J., Nollet F., Greco E., J. Urol., 145, 287-293 (1991).
2. Nathan H. P., Hellstrom W. J. G., Kaiser F. E., Labasky R. F., Lue T. F., Nolten W. E., Norwood P. C., Peterson C. A., Shabsigh R., Tam P. Y., Place V. A., Gesundheit N., N. Engl. J. Med., 336, 1-7 (1997).
3. Werthman P., Rajfer J., Urology, 50, 809-811 (1997).
4. Waldhauser M., Schramek P., J. Urol., 140, 525-527 (1988).
5. Levine S. B., Althof S. E., Turner L. A., Risen C. B., Bodner D. R., Kursh E. D., Resnick M. I., J. Urol., 141, 54-57 (1989).
6. Kim E. D., Mcvary K. T., J. Urol., 153, 1828-1830 (1995).
7. Maggi M., Filippi S., Ledda F., Eur. J. Endocrinol., 143, 143-154 (2000).
8. Palmer L. S., Valcic M., Melman A., J. Urol., 152, 1308-1314 (1994).
9. Igarashi R., Takenenage T., Matsuda T., Adv. Drug Deliv. Rev., 20, 147-154 (1996).
10. Mizushima Y., Adv. Drug Deliv. Rev., 20, 113-115 (1996).
11. Pouton C.W., Int. J. Pharm., 27, 335-348 (1985).
12. Shah N. H., Carvajal M. T., Patel C. I., Infeld M. H., Malick A. W., Int. J. Pharm., 106, 15-23 (1994).
13. Lawrence M. J., Rees G. D., Adv. Drug Deliv. Rev., 45, 89-121 (2000).
14. Charman S. A., Charman W. N., Rogge M. C., Wilson T. D., Dutko F. J., Pouton C. W., Pharm. Res., 9, 87-93 (1992).
15. Matuszewska B., Hettrics L., Bondi J. V., Storey D. E., Int. J. Pharm., 136, 147-154 (1996).
16. Khoo S. M., Humberstone A. J., Porter C. J. H., Edward G. A., Charman W. N., Int. J. Pharm., 167, 155-164 (1998).
17. Aboofazeli R., Lawrence M. J., Int. J. Pharm., 93, 161-175 (1993).
18. Wilhelmus K. R., Surv. Ophthalmol., 45, 493-515 (2001).
19. Susanne S., "Review of the Draize Eye Irritation Test," Diploma Thesis, Univ. Leipzig, Zürich, Mar. (2005).
20. Willimann H., Walde P., Luisi P. L., Gazzaniga A., Stroppolo F., J. Pharm. Sci., 81, 871-874 (1992).
21. Kemken J., Ziegler A., Müler B. W., J. Pharm. Pharmacol., 43, 679-684 (1991).
22. Kemken J., Ziegler A., Müler B. W., Pharm. Res., 9, 554-558 (1992).
23. Fujii M., Shiozawa K., Henmi T., Yomanouchi S., Suzuki H., Yamashita N., Matsumoto M., Int. J. Pharm., 137, 117-124 (1996).
24. Draize J. H., Woodard G., Calvery H. O., J. Pharmacol. Exp. Ther., 82, 377-390 (1944).
25. Janet A. J. H., Philip W. W., PSTT, 1, 309-316 (1998).
26. Lee K. C., Deluca P. P., J. Chromatogr., 555, 73-80 (1991).
27. Wang R., Higuera S. C., Sikka R. K., Minkes J. A., Urol. Res., 21, 75-78 (1993).
28. Champion H. C., Wang R., Shenassa B. B., Eur. J. Pharm., 319, 71-75 (1997).